Esplenectomía laparoscópica vs esplenectomía abierta

1. Canda AE, Sucullu I, Ozsoy Y, et al. Hospital experience, body image, and cosmesis after laparoscopic or open splenectomy. Surg Laparosc Endosc Percutan Tech. 2009;19:479–483.
2. Maurus CF, Schafer M, Muller MK, et al. Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg. 2008;32:2444–2449.
3. Boni L, Benevento A, Rovera F, et al. Infective complications in laparoscopic surgery. Surg Infect (Larchmt). 2006;7(suppl 2):S109–S111.
4. Zhou J, Wu Z, Cai Y, et al. The feasibility and safety of laparoscopic splenectomy for massive splenomegaly: a comparative study. J Surg Res. 2011;171:e55–e60.
5. Swanson TW, Meneghetti AT, Sampath S, et al. Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre. Can J Surg. 2011;54:189–193.
6. Zhu J, Ye H, Wang Y, et al. Laparoscopic versus open pediatric splenectomy for massive splenomegaly. Surg Innov. 2011;18:349–353.
7. Zhu JH, Wang YD, Ye ZY, et al. Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech. 2009;19:258–262.
8. Owera A, Hamade AM, Bani Hani OI, et al. Laparoscopic versus open splenectomy for massive splenomegaly: a comparative study. J Laparoendosc Adv Surg Tech A. 2006;16:241–246.
9. Koshenkov VP, Nemeth ZH, Carter MS. Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg. 2012;203:517–522.
10. Keckler SJ, Peter SD, Tsao K, et al. Laparoscopic excision of splenic cysts: a comparison to the open approach. Eur J Pediatr Surg. 2010;20:287–289.
11. Singla A, Li Y, Ng SC, et al. Is the growth in laparoscopic surgery reproducible with more complex procedures? Surgery. 2009;146:367–374.
12. Barbaros U, Dinccag A, Sumer A, et al. Prospective randomized comparison of clinical results between hand-assisted laparoscopic and open splenectomies. Surg Endosc. 2010;24:25–32.
13. Goers T, Panepinto J, Debaun M, et al. Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. Pediatr Blood Cancer. 2008;50:603–606.
14. Konstadoulakis MM, Lagoudianakis E, Antonakis PT, et al. Laparoscopic versus open splenectomy in patients with beta thalassemia major. J Laparoendosc Adv Surg Tech A. 2006;16:5–8.
15. Pomp A, Gagner M, Salky B, et al. Laparoscopic splenectomy: a selected retrospective review. Surg Laparosc Endosc Percutan Tech. 2005;15:139–143.
16. Kucuk C, Sozuer E, Ok E, et al. Laparoscopic versus open splenectomy in the management of benign and malign hematologic diseases: a ten-year single-center experience. J Laparoendosc Adv Surg Tech A. 2005;15:135–139.
17. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396–1407.
18. Khuri SF, Henderson WG, Daley J, et al. The patient safety in surgery study: background, study design, and patient populations. J Am Coll Surg. 2007;204:1089–1102.
19. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg. 2002;236:344–353; discussion 353–344.
20. ACS NSQIP User guide for the 2008 Participant Use Data File. Am Coll Surg. 2009:10–12.
21. Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134:647–653; discussion 654–655.
22. BaniHani MN, Qasaimeh GR, Bani-Hani KE, et al. Laparoscopic splenectomy: consensus and debatable points. S Afr J Surg. 2010;48:81–84.
23. Ohta M, Nishizaki T, Matsumoto T, et al. Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J Hepatobiliary Pancreat Surg. 2005;12:433–437.
24. Patle NM, Tantia O, Sasmal PK, et al. Laparoscopic splenectomy in patients of beta thalassemia: Our experience. J Minim Access Surg. 2010;6:70–75.
25. Feldman LS, Demyttenaere SV, Polyhronopoulos GN, et al. Refining the selection criteria for laparoscopic versus open splenectomy for splenomegaly. J Laparoendosc Adv Surg Tech A. 2008;18:13–19.
26. Fraser SA, Bergman S, Garzon J. Laparoscopic splenectomy: learning curve comparison between benign and malignant disease. Surg Innov. 2012;19:27–32.
27. Targarona EM, Cerdan G, Gracia E, et al. Results of laparoscopic splenectomy for treatment of malignant conditions. HPB (Oxford). 2001;3:251–255.
28. Casaccia M, Torelli P, Pasa A, et al. Putative predictive parameters for the outcome of laparoscopic splenectomy: a multicenter analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen. Ann Surg. 2010;251:287–291.
29. Fujita F, Lyass S, Otsuka K, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg. 2003;69:951–956.
30. Ikeda M, Sekimoto M, Takiguchi S, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 2005;241:208–216.
31. Wang H, Kopac D, Brisebois R, et al. Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy. Can J Surg. 2011;54:227–231.
32. Vecchio R, Cacciola E, Cacciola RR, et al. Portal vein thrombosis after laparoscopic and open splenectomy. J Laparoendosc Adv Surg Tech A. 2011;21:71–75.
33. Mohamed SY, Abdel-Nabi I, Inam A, et al. Systemic thromboembolic complications after laparoscopic splenectomy for idiopathic thrombocytopenic purpura in comparison to open surgery in the absence of anticoagulant prophylaxis. Hematol Oncol Stem Cell Ther. 2010;3:71–77.
34. Krauth MT, Lechner K, Neugebauer EA, et al. The postoperative splenic/portal vein thrombosis after splenectomy and its prevention—an unresolved issue. Haematologica. 2008;93:1227–1232.
35. Svensson M, Wiren M, Kimby E, et al. Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematological diseases. Eur J Haematol. 2006;77:203–209.
36. Xin Z, Qingguang L, Yingmin Y. Total laparoscopic versus open splenectomy and esophagogastric devascularization in the management of portal hypertension: a comparative study. Dig Surg. 2009;26:499–505.
37. Watanabe Y, Horiuchi A, Yoshida M, et al. Significance of laparoscopic splenectomy in patients with hypersplenism. World J Surg. 2007;31:549–555.
38. Vecchio R, Cacciola E, Lipari G, et al. Laparoscopic splenectomy reduces the need for platelet transfusion in patients with idiopathic thrombocytopenic purpura. JSLS. 2005;9:415–418.
39. Misawa T, Yoshida K, Iida T, et al. Minimizing intraoperative bleeding using a vessel-sealing system and splenic hilum hanging maneuver in laparoscopic splenectomy. J Hepatobiliary Pancreat Surg. 2009;16:786–791.
40. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208:931–937, 937 e931–e932; discussion 938–939.
41. Wu WC, Smith TS, Henderson WG, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010;252:11–17.
42. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011;114:283–292.
43. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 2012;147:49–55.
44. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127:295–307.
45. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97:1180–1195.
46. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941–1949.
47. Tinmouth A, Fergusson D, Yee IC, et al. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46:2014–2027.
48. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370:415–426.
49. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–1239.
50. Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008;22:821–848.
51. Pietrabissa A, Morelli L, Peri A, et al. Laparoscopic treatment of splenomegaly: a case for hand-assisted laparoscopic surgery. Arch Surg. 2011;146:818–823.
52. Reso A, Brar MS, Church N, et al. Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly. Surg Endosc. 2010;24:2008–2012.
53. Grahn SW, Alvarez J III, Kirkwood K. Trends in laparoscopic splenectomy for massive splenomegaly. Arch Surg. 2006;141:755–761; discussion 761–762.
54. Bell RL, Reinhardt KE, Cho E, et al. A ten-year, single institution experience with laparoscopic splenectomy. JSLS. 2005;9:163–168